Statins and the brain: New perspective for old drugs

被引:32
作者
Ling, Q. [1 ]
Tejada-Simon, M., V [1 ,2 ,3 ,4 ]
机构
[1] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX USA
[2] Univ Houston, Dept Biol, Houston, TX 77204 USA
[3] Univ Houston, Dept Psychol, Houston, TX USA
[4] Univ Houston, Biol Behav Inst BoBI, Houston, TX USA
关键词
Statin; Autism; Neurodegenerative disorders; Cognition; Cholesterol; HMG-COA REDUCTASE; FRAGILE-X-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; CHOLESTEROL-METABOLISM; COGNITIVE FUNCTION; LIPID RAFTS; MOUSE MODEL;
D O I
10.1016/j.pnpbp.2015.11.013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Statins are one of the most popular lipid-lowering drugs (LLDs). Upon oral administration, these drugs are well absorbed by the intestine and effectively used for the treatment of dyslipidemias. Recently, statins are becoming also well-known for their cholesterol-independent effects and their potential use in brain diseases and different types of cancers. While still controversial, recent research has suggested that statin's cholesterol-independent activities work possibly through alterations on isoprenoid levels. This reduction of isoprenoids in the central nervous system might result in effective biochemical and behavioral improvements on certain neurological disorders. This manuscript aims to highlight current research describing the use of statin therapy in the brain and discuss whether statins might affect neuronal dynamics and function independently of their cholesterol regulatory role. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:80 / 86
页数:7
相关论文
共 93 条
  • [1] Lovastatin as Treatment for Neurocognitive Deficits Type 1: Phase I Study
    Acosta, Maria T.
    Kardel, Peter G.
    Walsh, Karin S.
    Rosenbaum, Kenneth N.
    Gioia, Gerard A.
    Packer, Roger J.
    [J]. PEDIATRIC NEUROLOGY, 2011, 45 (04) : 241 - 245
  • [2] Statins more than cholesterol lowering agents in Alzheimer disease: Their pleiotropic functions as potential therapeutic targets
    Barone, Eugenio
    Di Domenico, Fabio
    Butterfield, D. Allan
    [J]. BIOCHEMICAL PHARMACOLOGY, 2014, 88 (04) : 605 - 616
  • [3] Use of statins and the risk of Parkinson's disease - A retrospective case-control study in the UK
    Becker, Claudia
    Jick, Susan S.
    Meier, Christoph R.
    [J]. DRUG SAFETY, 2008, 31 (05) : 399 - 407
  • [4] Statins, Risk of Dementia, and Cognitive Function: Secondary Analysis of the Ginkgo Evaluation of Memory Study
    Bettermann, Kerstin
    Arnold, Alice M.
    Williamson, Jeff
    Rapp, Stephen
    Sink, Kaycee
    Toole, James F.
    Carlson, Michelle C.
    Yasar, Sevil
    DeKosky, Steven
    Burke, Gregory L.
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2012, 21 (06) : 436 - 444
  • [5] HMG-CoA reductase inhibitors and P-glycoprotein modulation
    Bogman, K
    Peyer, AK
    Török, M
    Küsters, E
    Drewe, J
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (06) : 1183 - 1192
  • [6] Modulation of dendritic spines and synaptic function by Rac1: A possible link to Fragile X syndrome pathology
    Bongmba, Odelia Y. N.
    Martinez, Luis A.
    Elhardt, Mary E.
    Butler, Karlis
    Tejada-Simon, Maria V.
    [J]. BRAIN RESEARCH, 2011, 1399 : 79 - 95
  • [7] A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome
    Buchovecky, Christie M.
    Turley, Stephen D.
    Brown, Hannah M.
    Kyle, Stephanie M.
    McDonald, Jeffrey G.
    Liu, Benny
    Pieper, Andrew A.
    Huang, Wenhui
    Katz, David M.
    Russell, David W.
    Shendure, Jay
    Justice, Monica J.
    [J]. NATURE GENETICS, 2013, 45 (09) : 1013 - +
  • [8] Cholesterol-independent neuroprotective and neurotoxic activities of statins: Perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders
    Butterfield, D. Allan
    Barone, Eugenio
    Mancuso, Cesare
    [J]. PHARMACOLOGICAL RESEARCH, 2011, 64 (03) : 180 - 186
  • [9] Effect of Lovastatin on Behavior in Children and Adults with Fragile X Syndrome: An Open-Label Study
    Caku, Artuela
    Pellerin, David
    Bouvier, Pamela
    Riou, Emilie
    Corbin, Francois
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2014, 164 (11) : 2834 - 2842
  • [10] Lovastatin inhibits the extracellular-signal-regulated kinase pathway in immortalized rat brain neuroblasts
    Cerezo-Guisado, Maria Isabel
    Garcia-Roman, Natalia
    Garcia-Marin, Luis Jess
    Alvarez-Barrientos, Alberto
    Bragado, Maria Julia
    Lorenzo, Maria Jesus
    [J]. BIOCHEMICAL JOURNAL, 2007, 401 : 175 - 183